New preclinical data of COR-1389 in a model of right heart failure (RHF) were presented at the ESC 2024 in London. Chronic CRF2 agonism with COR-1389 improved dysregulated cardiac and pulmonary function and structure in a RHF rat model, suggesting its potential for the treatment of PH and RHF.
Menu